Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Myrrh

Also known as: Myrrh, Organic Myrrh, Commiphora myrrha

Overview

Myrrh, derived from the resin of the Commiphora myrrha tree, is a traditional herbal supplement recognized for its anti-inflammatory, antioxidant, and antimicrobial properties. It is commonly utilized in oral hygiene products, for wound healing, and as a complementary agent in liver protection and cancer adjunct therapy. While preclinical and in vitro studies show promising effects, large-scale human clinical trials are limited, indicating a need for more robust research to fully establish its efficacy and safety across various applications. The quality of evidence varies, with some promising findings from animal and in vitro studies, but a scarcity of high-powered randomized controlled trials in humans.

Benefits

Myrrh exhibits several potential health benefits, though the strength of evidence varies. It shows hepatoprotective effects, as demonstrated in an animal study where *C. myrrha* extract significantly reduced liver enzymes and oxidative stress markers induced by ethanol toxicity, suggesting liver protection and antioxidant capabilities. For anti-cancer potential, myrrh methanolic extracts have shown moderate cytotoxicity against various cancer cell lines (prostate, leukemia, breast) in vitro, with active metabolites like triterpenoids and steroids exhibiting cytotoxic effects. However, selective toxicity and in vivo efficacy require further validation. In oral health, a systematic review indicated myrrh's anti-inflammatory and anti-plaque effects, supporting its adjunctive use in managing gingivitis. Additionally, topical antioxidant formulations containing myrrh have shown efficacy in repigmentation for vitiligo patients, with significant clinical improvements observed over placebo in a randomized study.

How it works

Myrrh's therapeutic actions are primarily attributed to its bioactive compounds, including sesquiterpenoids, triterpenoids, and steroids. These compounds exert antioxidant effects by scavenging reactive oxygen species (ROS) and reducing lipid peroxidation, thereby protecting cells from oxidative damage. Its anti-inflammatory properties are mediated through the downregulation of inflammatory infiltrates and necrosis in affected tissues. The cytotoxic effects observed in cancer cells are thought to involve the induction of apoptosis and inhibition of proliferation, likely through specific molecular pathways influenced by compounds like guggulsterone. Information on oral absorption and bioavailability is limited, suggesting that the pharmacokinetics may vary depending on the specific extraction method and formulation of the resin.

Side effects

While generally considered safe at traditional doses, human safety data for myrrh are limited. Animal studies report good tolerability at doses up to 500 mg/kg without significant toxicity. Potential side effects in humans may include allergic reactions or gastrointestinal discomfort, though the frequency and severity of these are not well-quantified in controlled trials. There are no robustly documented significant drug interactions or contraindications. However, due to insufficient data, caution is advised for pregnant or breastfeeding women. It is important to note that myrrh should not replace conventional medical treatments, especially for serious conditions like cancer, and its use should be discussed with a healthcare professional.

Dosage

Effective doses for myrrh in animal studies are around 500 mg/kg orally, but human equivalent doses have not been firmly established through clinical trials. For topical applications, formulations used in clinical settings vary, but have shown efficacy in skin conditions when applied directly. There is no established maximum safe dose for humans. Clinical dosing should ideally follow traditional usage guidelines or be guided by future randomized controlled trials. Due to the limited human data, it is crucial to exercise caution and consult with a healthcare professional before initiating myrrh supplementation, especially for internal use.

FAQs

Is organic myrrh safe?

Current evidence suggests it is generally safe at traditional doses, but human clinical safety data are limited, especially for long-term use or high doses.

How soon do benefits appear?

Animal studies show biochemical improvements after 30 days; topical skin benefits may appear within months, but human data are scarce.

Can it be used for cancer treatment?

Preliminary in vitro data are promising, but clinical evidence is lacking. It should not replace conventional cancer therapies and requires further research.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9786033/ – This animal study investigated the hepatoprotective effects of myrrh extract against ethanol-induced liver damage in rats. It found that myrrh significantly reduced liver enzymes (ALT, AST), tumor markers, and oxidative stress, suggesting its potential as an antioxidant and liver protectant. The study was well-controlled but limited to an animal model.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9416713/ – This in vitro and in silico study explored the anti-cancer potential of myrrh metabolites. It demonstrated that myrrh compounds exhibited moderate cytotoxicity against various cancer cell lines (prostate, leukemia, breast), suggesting selective toxicity. However, the findings are limited to laboratory settings and require clinical validation.
https://jintegrativederm.org/doi/10.64550/joid.9jxazs21 – This randomized study evaluated the efficacy of topical antioxidant formulations containing myrrh for repigmentation in vitiligo patients. It reported significant clinical improvements over placebo, indicating myrrh's potential in managing skin conditions. The study provides clinical evidence for topical application.
https://opendentistryjournal.com/VOLUME/13/PAGE/1/FULLTEXT/ – This systematic review and meta-analysis assessed myrrh's role in oral health, specifically in gingivitis management. It concluded that myrrh demonstrated anti-inflammatory and anti-plaque effects as an adjunctive therapy. While a systematic review, it noted heterogeneity in studies and a lack of large-scale RCTs.